Harpoon Therapeutics (HARP) PT Lowered to $14 at Citi
Tweet
Share
E-mailGet Alerts HARP Hot Sheet
Price: $23.01 --0%
Rating Summary:
5 Buy, 7 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Rating Summary:
5 Buy, 7 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Join SI Premium – FREE
Citi analyst Yigal Nochomovitz lowered the price target on Harpoon Therapeutics (NASDAQ: HARP) to $14.00 (from $16.00) while maintaining a Buy rating.
You May Also Be Interested In
- Boston Scientific (BSX) PT Raised to $83 at Stifel
- Citi Upgrades United Microelectronics Corp (2303:TT) (UMC) to Buy 'with limited downside'
- Prudential Financial (PRU) PT Raised to $116 at Evercore ISI
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
